期刊文献+

胺碘酮、普罗帕酮、西地兰治疗阵发性房颤的效果比较 被引量:9

Comparison of amiodarone,propafenone and cedilanid in the treatment of paroxysmal atrial fibrillation
在线阅读 下载PDF
导出
摘要 目的 比较静脉应用胺碘酮、普罗帕酮、西地兰治疗阵发性房颤的效果。方法70例阵发性房颤患者随机分成胺碘酮组(n=26)、普罗帕酮组(n=20)、西地兰组(n=24),分别静脉推注胺碘酮150~600mg、普罗帕酮70~210mg、西地兰0.2~0.6mg,观察各组房颤的转复情况、复律时间、心室率变化及药物不良反应。结果胺碘酮组转复有效率优于普罗帕酮组和西地兰组(P〈0.05或0,01)。普罗帕酮组和胺碘酮组转复成功时间短于西地兰组(P〈0.01),其中普罗帕酮组最短。每组治疗前、后的平均心室率差异均有统计学意义(P〈0.01),胺碘酮组和普罗帕酮组治疗后的平均心室率优于西地兰组(P〈0.01)。结论胺碘酮转复心律的效果优于普罗帕酮和西地兰。 Objective To compare the effect of amiodarone, propafenone and eedilanid in the treatment of paroxysmal atrial fibrillation (PAF). Methods Seventy PAF patients were randomly divided into amiodarone group ( n = 26), propafenone group (n = 20)and cedilanid group (,1 = 24), receiving intravenous injection of amiodarone (150- 600 mg), propafenone (70- 210 mg)and cedilanid (0.2- 0.6 mg)respectively. The cardioversion, ventricular rate and adverse reaction were recorded in all groups. Results The cardioversion rate in arniodarone group was superior to that in propafenone and cedilanid groups (P 〈 0.01 or 0.05). The cardioversion time in propafenone and arniodarone group was shorter than that in cedilanid group (P〈0.01), especially in propafenone group. There was a statistical difference in the average ventricular rate between before and after treatment in three groups (P 〈 0.01), but the average ventricular rate after treatment in amiodarone and propafenone groups was lower than that in cedilanid group ( P 〈 0.01 ). Oonclusion Amiodarone is more effective than pmpafenone and cedilanid in the cardioversion of PAF.
出处 《广东医学院学报》 2009年第3期253-255,共3页 Journal of Guangdong Medical College
关键词 心房颤动 胺碘酮 普罗帕酮 西地兰 atrial fibrillation amiodarone propafenone cedilanid
作者简介 苏丹霞(1970-),女,学士,主治医师。
  • 相关文献

参考文献4

  • 1郭继鸿.心房颤动药物治疗的10个临床问题[J].中国实用内科杂志,2008,28(6):422-425. 被引量:38
  • 2Lip G Y,Tello-Montoliu A.Management of atrial fibrillation[J].Heart,2006,92(8):1177-1182.
  • 3Fuster V,Rydén L E,Cannom D S,et al.ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines[J].J Am Coll Cardiol,2006,48(4):854-906.
  • 4Lenis R V.Artrial fibrillation:the therapeutic options[J].Drugs,1990,40(6):641.

共引文献37

同被引文献60

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部